Cargando…
The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials
BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five Engli...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477641/ https://www.ncbi.nlm.nih.gov/pubmed/36118096 http://dx.doi.org/10.1155/2022/5589433 |
_version_ | 1784790407385710592 |
---|---|
author | Wu, Zhenhu Zheng, Yanchan Chen, Yaoxin He, Bing Wu, Lei Lin, Lin Xu, Yinji Chen, Yuanbin |
author_facet | Wu, Zhenhu Zheng, Yanchan Chen, Yaoxin He, Bing Wu, Lei Lin, Lin Xu, Yinji Chen, Yuanbin |
author_sort | Wu, Zhenhu |
collection | PubMed |
description | BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five English databases and four Chinese databases from their inceptions until December 2020. Randomized double-blind placebo-controlled trials were screened, and included studies evaluated routine pharmacotherapy (RP) plus AAHM versus RP plus placebo or AAHM versus placebo. The Cochrane risk of bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were performed to evaluate the methodological quality and quality of evidence separately. RESULTS: Sixteen studies involving 1,730 participants were included in this review. Compared with placebo plus RP, participants receiving long-term AAHM plus RP showed improvement in asthma quality of life questionnaire (AQLQ) with moderate-quality evidence (MD 6.53 points, 95% CI 2.70 to 10.36). Low-quality evidence indicated that AAHM plus RP was associated with improved FEV(1) (%) compared with placebo plus RP, whether long- or short-term use (MD 11.80%, 95% CI 2.84 to 20.76; MD 10.57%, 95% CI 8.40 to 12.74; respectively). Moderate-quality evidence showed that participants receiving short-term AAHM were associated with a higher AQLQ score (MD 6.57 points, 95% CI 3.76 to 9.38) and a lower frequency of acute exacerbations (MD –1.84, 95% CI –2.32 to –1.36) compared with placebo. Low-quality evidence also indicated that AAHM was associated with improved FEV(1) (L) compared with placebo, whether long- or short-term use (MD 0.35 litres, 95% CI 0.03 to 0.67; MD 0.66 litres, 95% CI 0.59 to 0.73; respectively). CONCLUSIONS: Moderate-quality evidence is promising that AAHM can improve the quality of life and reduce acute exacerbations in patients with asthma. AAHM also shows a positive role in improving lung function, but the evidence is so indefinite due to low quality. |
format | Online Article Text |
id | pubmed-9477641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-94776412022-09-16 The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials Wu, Zhenhu Zheng, Yanchan Chen, Yaoxin He, Bing Wu, Lei Lin, Lin Xu, Yinji Chen, Yuanbin Evid Based Complement Alternat Med Review Article BACKGROUND: Acupoint application of herbal medicine (AAHM) has been widely used in China. At present, there is no systematic review of AAHM versus placebo in the treatment of asthma. This systematic review aims to assess the efficacy of AAHM for asthma. METHODS: Searches were conducted in five English databases and four Chinese databases from their inceptions until December 2020. Randomized double-blind placebo-controlled trials were screened, and included studies evaluated routine pharmacotherapy (RP) plus AAHM versus RP plus placebo or AAHM versus placebo. The Cochrane risk of bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were performed to evaluate the methodological quality and quality of evidence separately. RESULTS: Sixteen studies involving 1,730 participants were included in this review. Compared with placebo plus RP, participants receiving long-term AAHM plus RP showed improvement in asthma quality of life questionnaire (AQLQ) with moderate-quality evidence (MD 6.53 points, 95% CI 2.70 to 10.36). Low-quality evidence indicated that AAHM plus RP was associated with improved FEV(1) (%) compared with placebo plus RP, whether long- or short-term use (MD 11.80%, 95% CI 2.84 to 20.76; MD 10.57%, 95% CI 8.40 to 12.74; respectively). Moderate-quality evidence showed that participants receiving short-term AAHM were associated with a higher AQLQ score (MD 6.57 points, 95% CI 3.76 to 9.38) and a lower frequency of acute exacerbations (MD –1.84, 95% CI –2.32 to –1.36) compared with placebo. Low-quality evidence also indicated that AAHM was associated with improved FEV(1) (L) compared with placebo, whether long- or short-term use (MD 0.35 litres, 95% CI 0.03 to 0.67; MD 0.66 litres, 95% CI 0.59 to 0.73; respectively). CONCLUSIONS: Moderate-quality evidence is promising that AAHM can improve the quality of life and reduce acute exacerbations in patients with asthma. AAHM also shows a positive role in improving lung function, but the evidence is so indefinite due to low quality. Hindawi 2022-01-31 /pmc/articles/PMC9477641/ /pubmed/36118096 http://dx.doi.org/10.1155/2022/5589433 Text en Copyright © 2022 Zhenhu Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Wu, Zhenhu Zheng, Yanchan Chen, Yaoxin He, Bing Wu, Lei Lin, Lin Xu, Yinji Chen, Yuanbin The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title | The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title_full | The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title_fullStr | The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title_full_unstemmed | The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title_short | The Role of Acupoint Application of Herbal Medicine for Asthma: Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials |
title_sort | role of acupoint application of herbal medicine for asthma: meta-analysis of randomized double-blind placebo-controlled trials |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477641/ https://www.ncbi.nlm.nih.gov/pubmed/36118096 http://dx.doi.org/10.1155/2022/5589433 |
work_keys_str_mv | AT wuzhenhu theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT zhengyanchan theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT chenyaoxin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT hebing theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT wulei theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT linlin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT xuyinji theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT chenyuanbin theroleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT wuzhenhu roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT zhengyanchan roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT chenyaoxin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT hebing roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT wulei roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT linlin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT xuyinji roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials AT chenyuanbin roleofacupointapplicationofherbalmedicineforasthmametaanalysisofrandomizeddoubleblindplacebocontrolledtrials |